Lumefantrine: Clinical Trials

5 trials of Lumefantrine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow Lumefantrine: new trials by email Literature Review of Lumefantrine trials Research Report on Lumefantrine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz
Ganaplacide, Lumefantrine, Efavirenz - Malaria
Phase 1CompletedNovartis Pharmaceuticals142022-04-282023-01-12
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir
Midazolam, Repaglinide, Dextromethorphan - Malaria
Phase 1CompletedNovartis Pharmaceuticals482022-03-092022-11-04
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole
Ganaplacide, Lumefantrine, Itraconazole - Malaria
Phase 1CompletedNovartis Pharmaceuticals192021-11-182022-10-28
Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali
PfSPZ Vaccine, Normal Saline, artemether 20mg/lumefantrine 120mg (AL) - Malaria
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)4782018-05-142021-08-20
Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects
ACT-451840:, Plasmodium falciparum-infected human erythrocytes:, Artemether 20 mg and lumefantrine 120mg combination tablet: - Healthy Subjects
Phase 1CompletedIdorsia Pharmaceuticals Ltd.82014-06-012019-08-22

Conditions studied

Malaria (5)  ·  Malaria, Falciparum (1)

Sponsors

Novartis Pharmaceuticals (3)  ·  Idorsia Pharmaceuticals Ltd. (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United Kingdom (3)  ·  Australia (1)  ·  Mali (1)

Top investigators

Michelle Lee (1)  ·  Patrick E Duffy, M.D. (1)

Results publications

PMID 27062080, PMID 39153490